"2 prizes for Incit at the Go Immuno congress - December 11 & 12, 2023".
INCIT in the spotlight at the "Go Immuno" conference organized by Labex IGO in December. In...
News :
New CRA funding for Team 3
Publication date: 4 May 2022
Read also:
read more
European funding for immunotherapy of inflammatory bowel diseases
HORIZON Europe Framework Program : coordinated by F. ALTARE INCIT joins the RAISE network...
"Deciphering the immune escape mechanism of the Epstein-Barr oncovirus and exploiting it as a therapeutic target for cancers linked to this virus".
Seminar Speaker: Marc Blondel (UBO Faculty of Medicine and Health Sciences)...
"Regulatory T cells control inflammatory and non-inflammatory pain through endogenous opioids".
Seminar Speaker: Gilles MARODON (Inserm U1135 | CIMI-PARIS | SiRiC Curamus) Location: MARCH 14,...
Read more articles
"2 prizes for Incit at the Go Immuno congress - December 11 & 12, 2023".
INCIT was honored at the "Go Immuno" conference organized by Labex IGO in December. Margaux Verdon (team 1) was awarded the prize for best poster, while Gwenann Cadiou (team 3) won the prize for best oral communication!
European funding for immunotherapy of inflammatory bowel diseases
The INCIT unit is pleased to announce that it has been awarded an ambitious European program on immunotherapy, bringing together 7 partners (including 2 biotechs) in 4 European countries. This program is coordinated by Frédéric ALTARE, Director of the UMR 1302, INCIT in Nantes. Project title: immunotherapy of inflammatory bowel diseases
"Deciphering the immune escape mechanism of the Epstein-Barr oncovirus and exploiting it as a therapeutic target for cancers linked to this virus".
Dr Marc Blondel (Faculté de Médecine et des Sciences de la Santé de l'UBO (Brest), invited by Team 2, will give a seminar entitled: Decrypting the immune escape mechanism of the Epstein-Barr oncovirus and exploiting it as a therapeutic target for cancers linked to this virus, on May 14 at 11.00 - Rooms 1, 2, 3 - IRS2, Nantes.
"Regulatory T cells control inflammatory and non-inflammatory pain through endogenous opioids".
Dr Gilles Marodon (Inserm U1135 | CIMI-PARIS | SiRiC Curamus), invited by Team 3, will give a seminar entitled: Regulatory T cells control inflammatory and non-inflammatory pain through endogenous opioids , on March 14 at 11.00 - Rooms 1, 2, 3 - IRS2, Nantes